{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:16:44Z","timestamp":1788509804047,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12264-026-01615-4","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:00:14Z","timestamp":1775898014000},"page":"1995-2009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Engineered Alzheimer Organoids Validate the Link Between Intracellular and Soluble p-Tau Biomarkers and Highlight the Contribution of Astrocytic Tau"],"prefix":"10.1007","volume":"42","author":[{"given":"Ru","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-2016","authenticated-orcid":false,"given":"Shichao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"1615_CR1","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 2020, 324: 772\u2013781.","journal-title":"JAMA"},{"key":"1615_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, et al. Plasma p-tau231: A new biomarker for incipient Alzheimer\u2019s disease pathology. Acta Neuropathol 2021, 141: 709\u2013724.","journal-title":"Acta Neuropathol"},{"key":"1615_CR3","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: A diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol 2020, 19: 422\u2013433.","journal-title":"Lancet Neurol"},{"key":"1615_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12264-022-00836-7","volume":"38","author":"S Huang","year":"2022","unstructured":"Huang S, Wang YJ, Guo J. Biofluid biomarkers of Alzheimer\u2019s disease: Progress, problems, and perspectives. Neurosci Bull 2022, 38: 677\u2013691.","journal-title":"Neurosci Bull"},{"key":"1615_CR5","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: Potential factors in amyloid plaque formation. J Neurosci 2006, 26: 10129\u201310140.","journal-title":"J Neurosci"},{"key":"1615_CR6","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/brv.12626","volume":"95","author":"Y Chang","year":"2020","unstructured":"Chang Y, Kim J, Park H, Choi H, Kim J. Modelling neurodegenerative diseases with 3D brain organoids. Biol Rev Camb Philos Soc 2020, 95: 1497\u20131509.","journal-title":"Biol Rev Camb Philos Soc"},{"key":"1615_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/dvdy.24662","volume":"248","author":"HI Chen","year":"2019","unstructured":"Chen HI, Song H, Ming GL. Applications of human brain organoids to clinical problems. Dev Dyn 2019, 248: 53\u201364.","journal-title":"Dev Dyn"},{"key":"1615_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41582-021-00578-6","volume":"18","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Victor MB, Tsai LH. Dissecting the complexities of Alzheimer disease with in vitro models of the human brain. Nat Rev Neurol 2022, 18: 25\u201339.","journal-title":"Nat Rev Neurol"},{"key":"1615_CR9","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","volume":"29","author":"B Bellaver","year":"2023","unstructured":"Bellaver B, Povala G, Ferreira PCL, Ferrari-Souza JP, Leffa DT, Lussier FZ, et al. Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease. Nat Med 2023, 29: 1775\u20131781.","journal-title":"Nat Med"},{"key":"1615_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12264-024-01258-3","volume":"41","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Liu H, Dai Z, He C, Qin S, Su Z. From physiology to pathology of astrocytes: Highlighting their potential as therapeutic targets for CNS injury. Neurosci Bull 2025, 41: 131\u2013154.","journal-title":"Neurosci Bull"},{"key":"1615_CR11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.2174\/1570159X15666170208124324","volume":"15","author":"P Muszy\u0144ski","year":"2017","unstructured":"Muszy\u0144ski P, Groblewska M, Kulczy\u0144ska-Przybik A, Ku\u0142akowska A, Mroczko B. YKL-40 as a potential biomarker and a possible target in therapeutic strategies of Alzheimer\u2019s disease. Curr Neuropharmacol 2017, 15: 906\u2013917.","journal-title":"Curr Neuropharmacol"},{"key":"1615_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41593-025-02115-w","volume":"29","author":"DJ Choi","year":"2026","unstructured":"Choi DJ, Murali S, Kwon W, Woo J, Song EC, Ko Y, et al. Astrocytic Sox9 overexpression in Alzheimer\u2019s disease mouse models promotes A\u03b2 plaque phagocytosis and preserves cognitive function. Nat Neurosci 2026, 29: 88\u201399.","journal-title":"Nat Neurosci"},{"key":"1615_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-022-01006-x","volume":"7","author":"S Huang","year":"2022","unstructured":"Huang S, Zhang Z, Cao J, Yu Y, Pei G. Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer\u2019s tau pathology. Signal Transduct Target Ther 2022, 7: 176.","journal-title":"Signal Transduct Target Ther"},{"key":"1615_CR14","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1007\/s12035-024-04557-y","volume":"62","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Li R, Zhou Y, Huang S, Hou Y, Pei G. Dietary flavonoid chrysin functions as a dual modulator to attenuate amyloid-\u03b2 and tau pathology in the models of Alzheimer\u2019s disease. Mol Neurobiol 2025, 62: 4274\u20134291.","journal-title":"Mol Neurobiol"},{"key":"1615_CR15","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1126\/science.abp9556","volume":"381","author":"S Balusu","year":"2023","unstructured":"Balusu S, Horr\u00e9 K, Thrupp N, Craessaerts K, Snellinx A, Serneels L, et al. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer\u2019s disease. Science 2023, 381: 1176\u20131182.","journal-title":"Science"},{"key":"1615_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41592-018-0103-2","volume":"15","author":"I Canals","year":"2018","unstructured":"Canals I, Ginisty A, Quist E, Timmerman R, Fritze J, Miskinyte G, et al. Rapid and efficient induction of functional astrocytes from human pluripotent stem cells. Nat Methods 2018, 15: 693\u2013696.","journal-title":"Nat Methods"},{"key":"1615_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","volume":"628","author":"MS Haney","year":"2024","unstructured":"Haney MS, P\u00e1lovics R, Munson CN, Long C, Johansson PK, Yip O, et al. APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature 2024, 628: 154\u2013161.","journal-title":"Nature"},{"key":"1615_CR18","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41593-020-00728-x","volume":"23","author":"K Richetin","year":"2020","unstructured":"Richetin K, Steullet P, Pachoud M, Perbet R, Parietti E, Maheswaran M, et al. Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer\u2019s disease. Nat Neurosci 2020, 23: 1567\u20131579.","journal-title":"Nat Neurosci"},{"key":"1615_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.152012","volume":"7","author":"LA Ezerskiy","year":"2022","unstructured":"Ezerskiy LA, Schoch KM, Sato C, Beltcheva M, Horie K, Rigo F, et al. Astrocytic 4R tau expression drives astrocyte reactivity and dysfunction. JCI Insight 2022, 7: e152012.","journal-title":"JCI Insight"},{"key":"1615_CR20","doi-asserted-by":"crossref","unstructured":"Zhou B, Lu JG, Siddu A, Wernig M, S\u00fcdhof TC. Synaptogenic effect of APP-Swedish mutation in familial Alzheimer\u2019s disease. Sci Transl Med 2022, 14: eabn9380.","DOI":"10.1126\/scitranslmed.abn9380"},{"key":"1615_CR21","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.3390\/cells9112415","volume":"9","author":"F Spanos","year":"2020","unstructured":"Spanos F, Liddelow SA. An overview of astrocyte responses in genetically induced Alzheimer\u2019s disease mouse models. Cells 2020, 9: 2415.","journal-title":"Cells"},{"key":"1615_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.npep.2018.12.003","volume":"73","author":"KG Ma","year":"2019","unstructured":"Ma KG, Qian YH. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer\u2019s disease. Neuropeptides 2019, 73: 96\u2013106.","journal-title":"Neuropeptides"},{"key":"1615_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.nbd.2011.09.002","volume":"45","author":"B DaRocha-Souto","year":"2012","unstructured":"DaRocha-Souto B, Coma M, P\u00e9rez-Nievas BG, Scotton TC, Siao M, S\u00e1nchez-Ferrer P, et al. Activation of glycogen synthase kinase-3 beta mediates \u03b2-amyloid induced neuritic damage in Alzheimer\u2019s disease. Neurobiol Dis 2012, 45: 425\u2013437.","journal-title":"Neurobiol Dis"},{"key":"1615_CR24","doi-asserted-by":"crossref","unstructured":"Stefanoska K, Gajwani M, Tan ARP, Ahel HI, Asih PR, Volkerling A, et al. Alzheimer\u2019s disease: Ablating single master site abolishes tau hyperphosphorylation. Sci Adv 2022, 8: eabl8809.","DOI":"10.1126\/sciadv.abl8809"},{"key":"1615_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","volume":"26","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Mattsson N, Palmqvist S, Smith R, Beach TG, Serrano GE, et al. Plasma P-tau181 in Alzheimer\u2019s disease: Relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nat Med 2020, 26: 379\u2013386.","journal-title":"Nat Med"},{"key":"1615_CR26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","volume":"20","author":"EH Thijssen","year":"2021","unstructured":"Thijssen EH, La Joie R, Strom A, Fonseca C, Iaccarino L, Wolf A, et al. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: A retrospective diagnostic performance study. Lancet Neurol 2021, 20: 739\u2013752.","journal-title":"Lancet Neurol"},{"key":"1615_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/BF00293315","volume":"87","author":"E Braak","year":"1994","unstructured":"Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994, 87: 554\u2013567.","journal-title":"Acta Neuropathol"},{"key":"1615_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0304-3940(95)11484-E","volume":"189","author":"M Goedert","year":"1995","unstructured":"Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995, 189: 167\u2013169.","journal-title":"Neurosci Lett"},{"key":"1615_CR29","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM. Synergistic Interactions between Abeta, tau, and alpha-synuclein: Acceleration of neuropathology and cognitive decline. J Neurosci 2010, 30: 7281\u20137289.","journal-title":"J Neurosci"},{"key":"1615_CR30","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","volume":"91","author":"AC Alonso","year":"1994","unstructured":"Alonso AC, Zaidi T, Grundke-Iqbal I, Iqbal K. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci U S A 1994, 91: 5562\u20135566.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1615_CR31","doi-asserted-by":"publisher","first-page":"12776","DOI":"10.1523\/JNEUROSCI.3463-09.2009","volume":"29","author":"GA Morfini","year":"2009","unstructured":"Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, Bosco DA, et al. Axonal transport defects in neurodegenerative diseases. J Neurosci 2009, 29: 12776\u201312786.","journal-title":"J Neurosci"},{"key":"1615_CR32","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1093\/hmg\/ddp367","volume":"18","author":"Y Wang","year":"2009","unstructured":"Wang Y, Martinez-Vicente M, Kr\u00fcger U, Kaushik S, Wong E, Mandelkow EM, et al. Tau fragmentation, aggregation and clearance: The dual role of lysosomal processing. Hum Mol Genet 2009, 18: 4153\u20134170.","journal-title":"Hum Mol Genet"},{"key":"1615_CR33","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med 2013, 19: 983\u2013997.","journal-title":"Nat Med"},{"key":"1615_CR34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian TJ, Aziz A, Meyer CF, Swenson BL, van Deursen JM, Baker DJ. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 2018, 562: 578\u2013582.","journal-title":"Nature"},{"key":"1615_CR35","first-page":"337","volume":"10","author":"AL Palmer","year":"2018","unstructured":"Palmer AL, Ousman SS. Astrocytes and aging. Front Aging Neurosci 2018, 10: 337.","journal-title":"Astrocytes and aging. Front Aging Neurosci"}],"updated-by":[{"DOI":"10.1007\/s12264-026-01663-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000}}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-026-01615-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-026-01615-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-026-01615-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:48:10Z","timestamp":1788508090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-026-01615-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1615"],"URL":"https:\/\/doi.org\/10.1007\/s12264-026-01615-4","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12264-026-01663-w","URL":"https:\/\/doi.org\/10.1007\/s12264-026-01663-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}